Search Results
Dec 10, 2025, 07:00 ET PreludeDx Announces First Independent Validation of AidaBreast™, the Only Multi-Omic Test to Predict Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer
at Royal Melbourne Hospital, Professor of Surgery at The University of Melbourne, and Principal Investigator of the study, together with Troy Bremer, PhD, Chief Scientific Officer of PreludeDx.The validation study, conducted at Royal Melbourne Hospital (RMH) in Australia, evaluated more than 400
More news about: Prelude Corporation
Dec 10, 2025, 07:00 ET CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
[email protected] Investor Relations Contact:Aman Patel, CFA & Adanna G. Alexander, PhDICR Healthcare [email protected]
More news about: Cytosorbents Corp
Dec 10, 2025, 04:12 ET Aerolase Earns Dual Honors in MedEsthetics 2025 Readers' Choice Awards
patients and practitioners need most--exceptional results without the pain, downtime, or limitations of traditional acne treatments," said Pavel Efremkin, PhD, Founder and CEO of Aerolase. "This award reflects the confidence that thousands of providers place in Neo Elite to deliver life-changing outcomes for
More news about: Aerolase
Dec 10, 2025, 03:00 ET Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
80% of real-world needs. Going further, it supports models scaling up to 120B LLM, delivering intelligence levels comparable to GPT-4o. This enables PhD-level reasoning, multi-step analysis, and deep contextual understanding — but with the security of fully offline, on-device processing.The announcement
More news about: Tiiny AI Inc.
Dec 09, 2025, 18:07 ET American Energy + AI Coalition Supports Passage of Effective Permitting Reform Bills
plan, permit, and build. This is a major opportunity to upgrade how energy projects move from idea to steel in the ground," said Ann Bluntzer Pullin, PhD, Executive Director of the Hamm Institute for American Energy. "Efforts that strengthen coordination and reduce redundancy can create predictable, efficient
More news about: CGCN Group
Dec 09, 2025, 16:00 ET Cirius Therapeutics to Highlight Cardiometabolic Benefits of CIR-0602K at Global Cardiovascular Clinical Trialists (CVCT) Forum 2025
innovative therapies for people suffering from diseases driven by insulin resistance and metabolic dysfunction, announced today that Robert Beardsley, PhD, Chief Executive Officer, will present a collection of data showcasing the potential of clinical candidate CIR-0602K to improve cardiometabolic risk
More news about: Cirius Therapeutics
Dec 09, 2025, 14:06 ET NCCN Summit Seeks to Improve Care for Veterans and First Responders with Cancer from Line-of-Duty Exposure
community is faced with an opportunity to ensure that veterans and first responders are connected to those programs and benefits."Erin Kobetz, PhD, MPH, Director and Principal Investigator for Sylvester Comprehensive Cancer Center's Firefighter Cancer Initiative, part of the University of Miami
More news about: National Comprehensive Cancer Network
Dec 09, 2025, 14:00 ET For A Bright Future Foundation Announces 2025 STEM Scholarship Recipients
Laveriano.Morelia Gil Cubillo is pursuing Chemical Engineering at UC Berkeley. Passionate about medical research, Morelia aspires to become an MD/PhD specializing in senility prevention, focusing on stem cell therapy and protein engineering to combat Alzheimer's disease." This scholarship not
More news about: Louis Hernandez Jr.'s Foundation For A Bright Future
Dec 09, 2025, 11:14 ET Regenerative Patch Technologies (RPT) Announces Treatment of First Two Patients in Phase IIb Clinical Trial Assessing the Safety and Efficacy of its Allogeneic Bioengineered RPE Cell Implant for the Treatment of Advanced Dry Age-Related Macular Degeneration.
that of the treated eye."Initiation of the Phase IIb clinical trial marks an important milestone for RPT," said Jane Lebkowski PhD, President of Regenerative Patch Technologies, LLC. "Based on our Phase I/IIa clinical trial results, the Phase IIb trial provides an opportunity to
More news about: Regenerative Patch Technologies
Dec 09, 2025, 10:00 ET a2z Radiology AI Raises $4.5M Seed Round to Scale Comprehensive CT Interpretation
work."The response at RSNA validated what we've been building—AI that considers everything from A to Z in each study," said Pranav Rajpurkar, PhD, co-founder of a2z Radiology AI and Associate Professor at Harvard Medical School. "This funding lets us keep pushing on R&D while bringing our cleared
More news about: a2z Radiology AI
Dec 09, 2025, 09:30 ET Lung Cancer Research Foundation Announces Recipients of LCRF | Boehringer Ingelheim Early Investigator Awards
Lung Cancer are:Pinar Özden Eser, PhDBroad Institute of MIT and HarvardIdentifying actionable targets to improve response to therapy among patients with HER2-driven NSCLCElizabeth Brunk, PhDThe University of North Carolina at Chapel
More news about: Lung Cancer Research Foundation
Dec 09, 2025, 09:16 ET Akadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance Program
www.akadeum.com. Akadeum Life Sciences Contact: Brandon McNaughton, PhD Chief Executive Officer [email protected]
More news about: Akadeum Life Sciences
Dec 09, 2025, 08:33 ET Tidal Metals and Alexander Chemical Corporation Announce Memorandum of Understanding for Chlorine Marketing and Distribution from Magnesium-from-Seawater Facility
with superior innovation brought to market through a peerless venture capital industry."About Tidal MetalsTidal Metals, founded by three PhD scientists from MIT, Princeton, and Wisconsin, is a deep-tech company based in New Jersey that has developed a breakthrough suite of innovations for
More news about: Tidal Metals
Dec 09, 2025, 08:00 ET A Wake-up Call for Executives: Three Critical Trends That Will Reshape Leadership
demonstrate strong collaboration and analytical thinking, but struggle in key areas such as empathy, adaptability and resilience," explained Carolyn Hass PhD, Chief Operating Officer at SuccessFinder. "To bridge the gap, organizations need a data-driven approach to identify their leadership challenges, define
More news about: SuccessFinder
Dec 09, 2025, 08:00 ET Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk
stage.Vincere is part of a multi-center study led by Massimo Cristofanilli, MD, at Weill Cornell Medicine in collaboration with Professor Kristina Rinker, PhD, co-Principal Investigator at the University of Calgary and Cofounder of Syantra Inc. The study aims to generate additional evidence to support clinical
More news about: Syantra Inc.
Dec 09, 2025, 08:00 ET Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
support the vision to transform drug discovery with purpose-built, relevant in vitro models coupled with cutting edge AI."Dr. Natalie Ma, PhD, Head of Business Development at Deep Origin, shared "Ginkgo's high throughput in vitro platforms mean we can generate data at scale, enabling detailed
More news about: Ginkgo Bioworks
Dec 09, 2025, 07:30 ET Pirtobrutinib Outperforms Bendamustine Plus Rituximab for Previously Untreated CLL/SLL
were able to prove that pirtobrutinib is an excellent drug both in terms of efficacy and tolerance," said lead study author Wojciech Jurczak, MD, PhD, professor of hematology at the National Research Institute of Oncology in Kraków, Poland. "Our data show that it is not just overcoming resistance
More news about: American Society of Hematology
Dec 09, 2025, 07:30 ET Drug Reduced Need for Blood Transfusions During Hospitalization for Non-Cardiac Surgery
reduces the need for blood transfusion in patients undergoing higher-risk non-cardiac surgery," said lead study author Brett Houston, MD, PhD, an assistant professor at the University of Manitoba and a scientist with the Paul Albrechtsen Research Institute in Winnipeg, Canada. "We were also
More news about: American Society of Hematology
Dec 09, 2025, 07:30 ET Tec-Dara Combination Offers Substantial Improvement Over Standard Second-Line Therapies for Relapsed or Refractory Multiple Myeloma
myeloma."We were surprised by the efficacy data because we didn't expect such a magnitude of benefit," said lead study author María-Victoria Mateos, MD, PhD, physician in the haematology department and professor of medicine at the University of Salamanca in Spain. "These are the best data we've seen in
More news about: American Society of Hematology
Dec 09, 2025, 07:30 ET Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting
real-world evidence base supporting the use of sutimlimab therapy for patients with cold agglutinin disease," commented Alessandro Albuquerque, MD, PhD, Chief Medical Officer and Vice President of Medical Affairs and Clinical Development at Recordati. "Recordati remains committed to meeting the needs
More news about: Raliance Communications
Dec 09, 2025, 07:30 ET Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
significant effect size, among the most pronounced ever observed for a single agent BTK inhibitor in a front-line CLL study," said Wojciech Jurczak, MD, PhD, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland. "The magnitude of the progression-free survival benefit, early overall
More news about: Eli Lilly and Company
Dec 09, 2025, 05:07 ET Exercise Might Help Improve Mobility During Aging
Bastioli, PhD, a former postdoctoral fellow at NYU Langone Health, is the study lead author. She is now at Vita-Salute San Raffaele University.Other NYU Langone researchers involved in the study are Maria Mancini, PhD; Jyotiben Patel, PhD; Begoña Gamallo-Lana, PhD; Jennifer Arnold, PhD; and Adam
More news about: NYU Grossman School of Medicine and NYU Langone Health
Dec 08, 2025, 17:06 ET CHARISM: Catholic Higher Education Alliance of Rising Institutions in Service and Mission
journeys."The establishment of CHARISM represents a strategic alignment of Catholic mission and higher education innovation," says Thomas M. Evans, PhD, UIW president. "In his recent Apostolic letter, Pope Leo XIV delivered a new mandate for Catholic education to work together to meet the needs of our
More news about: University of the Incarnate Word
Dec 08, 2025, 16:15 ET Vapotherm and Flight Medical Announce Partnership to Bring the VentO2ux™ Ventilator to US Hospitals
Departments."Clinicians tell us every day that they need tools that are simple to use, reliable, and focused on patient comfort." said Jessica Whittle, MD, PhD, Chief Medical Officer at Vapotherm. "By adding VentO2ux to our product line, we are extending Vapotherm's legacy of patient comfort focused respiratory
More news about: Vapotherm, Inc.
Dec 08, 2025, 14:45 ET Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study
potential for people living with Glanzmann thrombasthenia, who have waited a lifetime for a modern prophylactic treatment," said Benny Sorensen, MD, PhD, Chief Executive Officer of Hemab. "The clinically meaningful reductions in bleeding demonstrated across this study provide compelling evidence that
More news about: Hemab Therapeutics